Engineering - Biopharmaceutical Engineering

Pharmaceutical and Biopharmaceutical manufacturing are key sectors in the Irish economy generating over 50 per cent of GDP. This sector has seen continued and sustained success with a number of high profile investments in recent years providing excellent job opportunities for graduates. The programme and its academic faculty are closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excellence for training and research in bioprocessing.



This MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry. This programme offers an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.

Stage 1 Options - A) Min 6 of:

YEAR 1 CORE MODULES: Year 1 Students must select all 6 modules in the module list

CHEN40670 Biotechnology & Biopharma Autumn 5

CHEN40720 Principles of Biopharmaceutical Engineering (PT) Autumn 5

CHEN40730 Animal Cell Culture Technology (PT) Autumn 5

CHEN40090 Bioprocessing Laboratory Spring 5

CHEN40710 Downstream Processing & Sterile Fill Finish (PT) Spring 5

CHEN40850 Cell Therapy Tech & Processing Spring 5



Stage 1 Options - B) Min 7 of:

YEAR 2 CORE MODULES: Year 2 Students must select 3 modules in Autumn and 3 module in Spring (CHEN40130, CHEN40650 and 1 other module) and the 30 credit project module.

CHEN40110 Facility Design and Operation Autumn 5

CHEN40120 Biopharmaceutical Industry Regulation and Management Autumn 5

CHEN40630 Bioanalytical Science for Biopharma Autumn 5

CHEN40130 Bioprocess Scale-up and Technology Transfer Spring 5

CHEN40650 Research Methodologies Spring 5

CHEN40860 Gene Ther & Vacc Tech & Proc Spring 5

CHEN40870 GMP Manufact Advan Therapeutic Spring 5

CHEN40140 Biopharmaceutical Engineering Project Summer 30

- An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account.

- Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent. For more information please click here.

- Students must be working full-time in the Pharma/Biopharma or a related sector.



These are the minimum entry requirements – additional criteria may be requested for some programmes.



You may be eligible for Recognition of Prior Learning (RPL), as UCD recognises formal, informal, and/or experiential learning. RPL may be awarded to gain Admission and/or credit exemptions on a programme. Please visit the UCD Registry RPL web page for further information. Any exceptions are also listed on this webpage.

https://tinyurl.com/2ae2ffax

90

2 years part-time.

DELIVERY: On Campus

MEngSc Biopharmaceutical Engineering (T070) Full Time

EU fee per year - € 8085

nonEU fee per year - € 25600


***Fees are subject to change


Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see http://www.ucd.ie/global/study-at-ucd/scholarshipsfinances/scholarships/.


The College of Engineering & Architecture also offer scholarships for non-EU students, for more information see: www.ucd.ie/eacollege/study/noneuscholarships.

T015 MEngSc in Biopharmaceutical Engineering Master of Engineering Science Part-Time

Commencing September 2025

Graduate Taught

Career & Graduate Study Opportunity

Graduates from this programme are highly sought after and play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years. Ireland is a world player in pharmaceutical and biopharmaceutical production.



The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world including AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.